Name
MediBeacon
What We Do
The goal of MediBeacon’s focus on fluorescent tracer agents and their transdermal detection is to provide actionable organ function assessment. The MediBeacon® Transdermal GFR System is approved for human use for assessment of kidney function. There are over 600 peer-reviewed publications and conference abstracts on preclinical transdermal GFR methodology use.
Website
https://www.medibeacon.com/
Address
Theodor-Kutzer-Ufer 1-3
Mannheim, 68167
Germany

Organization Member List

Sabine Neudecker